Instrument Inactif

Communiqués The Valens Company Inc.

Actions

VLNS

CA91914P6030

Produits pharmaceutiques

Communiqués

17/01/23	SNDL Completes Acquisition of The Valens Company	AQ
14/12/22	The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule	AQ
29/11/22	Valens Shareholders Vote in Favour of the Arrangement with SNDL	PR
22/11/22	BOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC.	AQ
02/11/22	Valens Secures Sales Licence for Greater Toronto Area Beverage Facility	AQ
27/10/22	THE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC.	AQ
13/10/22	The Valens Company Reports Third Quarter Fiscal 2022 Financial Results	AQ
06/10/22	The Valens Company to Release Financial Results for the Third Quarter of 2022	AQ
22/08/22	IIROC Trade Resumption - VLNS	AQ
22/08/22	SNDL Announces Agreement to Acquire The Valens Company to Create Leading Vertically Integrated Cannabis Platform	AQ
22/08/22	IIROC Trading Halt - VLNS	AQ
03/08/22	Valens : Announces Results of Annual General Meeting of Shareholders - Form 6-K	PU
03/08/22	The Valens Company Announces Results of Annual General Meeting of Shareholders	AQ
21/07/22	Valens : Announces Nomination of Independent Director to Board of Directors - Form 6-K	PU
19/07/22	The Valens Company Announces Nomination of Independent Director to Board of Directors	AQ
14/07/22	Valens : Reports Second Quarter Fiscal 2022 Financial Results - Form 6-K	PU
13/07/22	Valens : CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K	PU
13/07/22	The Valens Company Reports Second Quarter Fiscal 2022 Financial Results	AQ
12/07/22	Valens : ANNUAL GENERAL MEETING OF THE SHAREHOLDERS OF - Form 6-K	PU
07/07/22	Valens : to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022 - Form 6-K	PU
06/07/22	The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2022	AQ
28/06/22	Valens : Notice of Meeting and Record Date dated June 27, 2022 - Form 6-K	PU
23/06/22	Valens : Signs Exclusive Cannabis Partnership with Coldhaus Distribution - Form 6-K	PU
22/06/22	The Valens Company Signs Exclusive Cannabis Partnership with Coldhaus Distribution	AQ
16/06/22	Valens : Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Form 6-K	PU